Friday, October 19, 2012

Psoriasis: Investigation found a clear association between psoriasis and diabetes

An analysis of 27 studies linking psoriasis in 314,000 individuals with diabetes has found strong correlation between the scaly skin rash and the blood sugar disorder that predisposes patients to heart disease, say UC Davis researchers who led the review.

Wednesday, October 17, 2012

Nuclear Medicine: New Radiation Treatment Significantly Increases Survival Rate

A novel drug that mimics a naturally occurring molecule found in coffee and blueberries has been developed to treat radiation exposure. Charles R. Yates, Pharm.D., Ph.D., and colleagues Duane Miller, Ph.D., and Waleed Gaber, Ph.D.,

Monday, October 15, 2012

Cosmetic Medicine: Sea cucumbers and sea urchins are able to change the elasticity of collagen within their bodies

Sea cucumbers and sea urchins are able to change the elasticity of collagen within their bodies, and could hold the key to maintaining a youthful appearance, according to scientists at Queen Mary, University of London.

Sunday, October 14, 2012

Drinking alcohol and smoking have to throw together

New research verifies previous studies by Dr. Timothy Durazzo and his colleagues, showing that smoking, while trying to quit drinking alcohol, impairs learning, memory, and other cognitive skills, hindering successful sobriety.

Wednesday, October 10, 2012

Value-based pricing is one potential solution to reduce the cost of drugs

A virtual monopoly held by some drug manufacturers in part because of the way treatment protocols work is among the reasons cancer drugs cost so much in the United States, according to a commentary by two Mayo Clinic physicians in the October issue of the journal Mayo Clinic Proceedings. Value-based pricing is one potential solution, they write.

Tuesday, October 9, 2012

Subcutaneous Formulation Of ORENCIA® (Abatacept) Approved By European Commission

Bristol-Myers Squibb have announced that the European Commission has granted marketing authorisation for the subcutaneous formulation of ORENCIA® (abatacept), in combination with methotrexate (MTX), for the treatment of adults with moderate to severe active rheumatoid arthritis (RA).

Sunday, October 7, 2012

Cardiology: Heart Attack Mortality Risk Greater For People With Schizophrenia

The risk of death resulting from heart attack is higher in people with schizophrenia than in the general public, according to scientists at the Centre for Addiction and Mental Health (CAMH) and the Institute for Clinical Evaluative Sciences (ICES).